A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis
2022-06-28
عنوان الدراسة
A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis
داعم الدراسة
Novartis
دواء الدراسة
ofatumumab
رقم بروتوكول الدراسة
COMB157G2301
حالة الدراسة
Ongoing
موقع الدراسة
KFSH&RC-J
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.